|
Volumn , Issue , 2009, Pages 371-381
|
Management of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BCR ABL PROTEIN;
BISPECIFIC ANTIBODY;
CORTICOSTEROID;
DASATINIB;
IMATINIB;
MT 103 ANTIBODY;
MT-103 ANTIBODY;
PIPERAZINE DERIVATIVE;
PROTEIN KINASE INHIBITOR;
PYRIMIDINE DERIVATIVE;
THIAZOLE DERIVATIVE;
TUMOR PROTEIN;
ACUTE LYMPHOBLASTIC LEUKEMIA;
ADOLESCENT;
ADULT;
ARTICLE;
CANCER INVASION;
CENTRAL NERVOUS SYSTEM;
CHILD;
DRUG ANTAGONISM;
DRUG RESISTANCE;
ENZYMOLOGY;
GENETICS;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
METHODOLOGY;
MINIMAL RESIDUAL DISEASE;
MULTIMODALITY CANCER THERAPY;
MUTATION;
PATHOLOGY;
PHILADELPHIA 1 CHROMOSOME;
RECURRENT DISEASE;
SALVAGE THERAPY;
ADOLESCENT;
ADRENAL CORTEX HORMONES;
ADULT;
ANTIBODIES, BISPECIFIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CENTRAL NERVOUS SYSTEM;
CHILD;
COMBINED MODALITY THERAPY;
DRUG RESISTANCE, NEOPLASM;
FUSION PROTEINS, BCR-ABL;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
LEUKEMIC INFILTRATION;
MUTATION;
NEOPLASM PROTEINS;
NEOPLASM, RESIDUAL;
PHILADELPHIA CHROMOSOME;
PIPERAZINES;
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;
PROTEIN KINASE INHIBITORS;
PYRIMIDINES;
RECURRENCE;
SALVAGE THERAPY;
THIAZOLES;
TRANSPLANTATION CONDITIONING;
|
EID: 77949474724
PISSN: None
EISSN: 15204383
Source Type: Journal
DOI: 10.1182/asheducation-2009.1.371 Document Type: Article |
Times cited : (80)
|
References (0)
|